Vijendar Dwarakanath Portfolio
Invests via Napean Trading & Investment Co (Singapore) PTE Ltd | Managed by Vijendar Dwarakanath
Invests via Napean Trading & Investment Co (Singapore) PTE Ltd
Managed by Vijendar Dwarakanath
Automatically Tracked
Vijendar Dwarakanath Profile
Veteran life-sciences investor and entrepreneur focused on early-stage biotechnology and oncology therapeutics. Vijendar Dwarakanath combines operating R&D experience with venture investing, serving on corporate boards and advising clinical-stage companies. Known for sourcing translational assets, structuring financing rounds, and navigating regulatory and partnering pathways.
Veteran life-sciences investor and entrepreneur focused on early-stage biotechnology and oncology therapeutics. Vijendar Dwarakanath combines operating R&D experience with venture investing, serving on corporate boards and advising clinical-stage companies. Known for sourcing translational assets, structuring financing rounds, and navigating regulatory and partnering pathways.
Investment Philosophy & Strategy
Combines operational R&D experience with venture-style, early-stage biotech investing, prioritizing translational oncology assets with clear clinical paths and partnerable mechanisms. Uses deep scientific due diligence and milestone-driven, staged capital to de-risk programs, preferring syndication with strategic pharma and experienced co-investors. Active governance and hands-on portfolio support accelerate development, regulatory strategy, and partnering readiness. Time horizon is long, patient capital calibrated to clinical inflection points; risk discipline centers on robust preclinical-to-clinic evidence, clear go/no-go criteria, and exit through strategic partnerships or clinical value creation.
Combines operational R&D experience with venture-style, early-stage biotech investing, prioritizing translational oncology assets with clear clinical paths and partnerable mechanisms. Uses deep scientific due diligence and milestone-driven, staged capital to de-risk programs, preferring syndication with strategic pharma and experienced co-investors. Active governance and hands-on portfolio support accelerate development, regulatory strategy, and partnering readiness. Time horizon is long, patient capital calibrated to clinical inflection points; risk discipline centers on robust preclinical-to-clinic evidence, clear go/no-go criteria, and exit through strategic partnerships or clinical value creation.
Disclaimer: This Portfolio is derived from and computed based on publicly available data from SEC filings.
Gain and growth charts are calculated per selected timeframe:
102.79%
Gain +0.24%
Monthly
2.43%
Yearly
33.38%
Drawdown
25.11%
$696.8M
Equity
Holdings
$696.8M
Investment
$320.75M
$395.78M
Profit +$1.86M
Realized
$19.72M
Unrealized
$376.06M
Dividends
$3.94M
Goals
Avg. 100% completed goals
Yearly
Gain > 5% 2026
Yearly
Gain < 20% 2026
Today
Compared To Yesterday
Gain
0.24%
Profit
$1.86M
Win %
58%
This Week
Compared To Last Week
Gain
0.29%
Profit
$2.04M
Win %
58%
This Month
Compared to last month
Gain
-2.46%
Profit
-$17.56M
Win %
58%
This Year
Compared to last year
Gain
14.54%
Profit
$88.45M
Win %
58%
YI 111, Inc. American Depositary Receipt
+14.25%
+$23,982.82 
AMD Advanced Micro Devices, Inc.
+4.73%
+$909,933.84 
BE Bloom Energy Corporation
+4.56%
+$4.57M 
ANET Arista Networks, Inc.
+4.37%
+$285,802.56 
IOT Samsara Inc. Class A Common Stock
+4.34%
+$168,785.4 
P Everpure Inc.
+4.28%
+$440,890.56 
LRCX Lam Research Corporation
+1.18%
+$795,035.67 
LSCC Lattice Semiconductor Corporation
+1.17%
+$125,535.57 
AZO AutoZone Inc.
+1.12%
+$125,610.96 
HOOD Robinhood Markets, Inc.
+1.04%
+$1.51M 
UNH UnitedHealth Group Incorporated
+0.73%
+$119,284.11 
HD The Home Depot, Inc.
+0.73%
+$72,856.56 
MA Mastercard Incorporated
+0.71%
+$50,432.98 
PYPL PayPal Holdings Inc
+0.7%
+$21,715.2 
GOOGL Alphabet Inc
+0.53%
+$86,242.23 
NTNX Nutanix, Inc.
+0.2%
+$8,119.8 
NVDA NVIDIA Corporation
+0.16%
+$43,796.8 
MSFT Microsoft Corp.
+0.1%
+$10,342.8 
TJX The TJX Companies, Inc.
+0.04%
+$10,765.72 
ANSS Ansys, Inc.
0%
$0 
ANTM Anthem Inc
0%
$0 
SNOW
0%
$0 
ADSK Autodesk, Inc.
-3.47%
-$78,297.24 
ICLR ICON plc
-2.5%
-$90,519.22 
SHOP Shopify Inc.
-2.02%
-$227,034.07 
AAPL Apple Inc.
-1.52%
-$180,166.5 
CRWD CrowdStrike Holdings, Inc.
-1.26%
-$141,556.95 
AMZN Amazon.com Inc
-1.23%
-$344,277.6 
NFLX Netflix, Inc.
-1.14%
-$211,426.2 
UBER Uber Technologies, Inc.
-1.01%
-$52,105.2 
AVGO Broadcom Inc.
-0.91%
-$272,954.5 
SNPS Synopsys, Inc.
-0.53%
-$73,648.8 
MCK McKesson Corporation
-0.4%
-$23,923.66 
DHR Danaher Corporation
-0.38%
-$38,292.93 
META Meta Platforms Inc Class A
-0.26%
-$60,088 Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 163 | Longs Won 91/163 55% | Profit Factor 12.77 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $11.94M |
| Average Win $4.72M | Best Trade (Jun 14) $126.82M | Sharpe Ratio -68.07 |
| Average Loss -$466,965.66 | Worst Trade (Jun 14) -$3.42M | Z-Score 0.81 (58.42%) |
| Commissions $0 | Avg. Trade Length 1y 2m 3w 3d | Expectancy $2.43M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.02% | 0.52% | 8.36% |
| Consecutive Losing Trades | 1,493 | 1,343 | 1,194 | 1,045 | 896 | 746 | 597 | 448 | 299 | 149 |
Hover over the desired column for a detailed explanation.
Returns
Overall, MonthlyNo Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
